Michael C. Alfano, D.M.D., Ph.D., was named NYU’s Executive Vice President by President John Sexton in June 2006. As executive vice president, he oversees the University's budget and finance operations, the human relations division, and the real estate, planning, and construction operations.
Prior to being named Executive Vice President, Dr. Alfano was Dean of the NYU College of Dentistry, a post he had held since 1998; he continues as a professor of basic science and craniofacial biology at the College of Dentistry. Prior to that post, he was the Senior Vice President for research and technology and a member of the Board of Directors at the Block Drug Company, Inc, now a unit of Glaxo Smith Kline. At Block he was responsible for all research, technology and quality assurance on a global basis.
Dr. Alfano is a highly respected and innovative educator, practitioner, researcher, and industry professional. Throughout his career, his professional focus has been on enhancing oral and general health through better therapy, public education, and challenging the dental profession to become even more effective. During the last three decades, he has worked to promote improved communications among academic, industrial, and government scientists; regulatory agencies; and the public. In addition, he has led in the development and clinical evaluation of new products for both the dental and pharmaceutical industries.